Our latest laboratory research on FSK discovered that it is vital in preventing oligodendrocyte cell degeneration and death in neurodegenerative illnesses such as multiple sclerosis and amyotrophic lateral sclerosis (ALS) by activating the cAMP and CREB pathways [24,25]. Here, CREB1 is linked to amyotrophic lateral sclerosis.